Tuberculosis News and Research

Latest Tuberculosis News and Research

Also in global health news: Africa measles eradication; water, food security in South Asia; MDR-TB in Mumbai; SADC summit; U.S. Cuba embargo

WHO Regional Director for Africa Luis Gomes Sambo said Tuesday during the 59th Session of the WHO Regional Committee for Africa in Kigali, Rwanda, that measles could be eradicated from the continent by 2020, citing an 89 percent reduction in the number of deaths caused by measles between 2000 and 2007, Angencia AngolaPress reports.

4 Sep 2009

Increase in Rifampicin dosage shortens tuberculosis treatment duration

According to Dutch researcher Hanneke Later-Nijland, it may be possible to shorten the duration of treatment for tuberculosis. Due to the long duration of treatment, not every patient sees it through. Partly because of this, tuberculosis is one of the most lethal diseases in developing countries.

3 Sep 2009

Cimzia approved for treating adult patients with rheumatoid arthritis

UCB Canada Inc. announced today that Health Canada has approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).

1 Sep 2009

Also in Global Health news: Flu, cholera in PNG; improving life awards; HIV/AIDS in Rwanda; men and maternal/child health; MDR-TB in India

"Twin outbreaks of a flu-like illness and dysentery in a remote region of Papua New Guinea have killed 47 people and infected another 2,000 villagers, a senior medical official said Monday," Agence France-Presse reports. According to provincial health adviser Doctor Theo Likei, the WHO has collected and is testing samples of the virus from the "stricken villages" (8/31). Additionally, the country is experiencing a cholera outbreak - "the first time the disease has officially been confirmed in the country," the BBC reports (Mercer, 8/31).

1 Sep 2009

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

The Infectious Disease Research Institute (IDRI) and NanoPass Technologies Ltd. (NanoPass) today announced they have entered into an agreement whereby IDRI licenses NanoPass' proprietary MicronJet microneedle technology for the intradermal delivery of products against a number of diseases including tuberculosis, HIV, malaria, leishmaniasis and leprosy, among others. The financial details of the agreement are confidential.

31 Aug 2009

Also in Global Health news: ARVs in Uganda; Brazil's fight against HIV/AIDS

Zainab Akol, Uganda's AIDS Control Program director, said the health ministry has acquired enough antiretroviral (ARV) drugs to provide treatment for people living with HIV/AIDS until the end of the year, New Vision reports. In addition to 30 tons of drugs, the ministry received at the beginning of August from the Global Fund to Fight AIDS, Tuberculosis and Malaria, it also purchased ARVs worth about $20 million this month, Akol said (Kagolo, 8/27).

29 Aug 2009

Urine LAM-ELISA's sensitivity of 50.7% in identifying TB disappoints

Urine LAM-ELISA does not appear to be useful as an independent diagnostic test for pulmonary tuberculosis (TB). A trial of the new diagnostic, described in the open access journal BMC Infectious Diseases found that it was only capable of identifying 50.7% of TB cases.

28 Aug 2009

Enzymes could be targeted to kill dangerous pathogens

Researchers at Burnham Institute for Medical Research (Burnham), University of Texas Southwestern Medical Center and University of Maryland have demonstrated that an enzyme that is essential to many bacteria can be targeted to kill dangerous pathogens.

28 Aug 2009

Also in global health news: NTD study; false cholera cases in Zimbabwe; contaminated water in Kenya; doctor's strike ends

UPI reports on a recent review article in the journal PLoS Neglected Tropical Diseases that analyzed the toll of neglected tropical diseases on populations in sub-Saharan Africa. "Researchers said helminth (parasitic worm) infections account for approximately 85 percent of the neglected tropical diseases, which overall might be equivalent to more than double that caused by tuberculosis and as much as half of the area's malaria disease burden," the news service writes (8/26).

28 Aug 2009

Clinical data added to ORENCIA labeling help treat patients with rheumatoid arthritis

Bristol-Myers Squibb Company announced today that clinical data added to the labeling for ORENCIA (abatacept) support use of ORENCIA for patients with moderate to severe rheumatoid arthritis of less than or equal to two years duration.

27 Aug 2009

European Medicines Agency validates Schering-Plough's MAA for nomegestrol acetate/17 beta-estradiol

Schering-Plough Corporation, (NYSE: SGP), today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the maintenance treatment of asthma in patients 12 years of age and older.

27 Aug 2009

Movember to present at the LIVESTRONG Global Cancer Summit

Staggering statistic: cancer kills more people every year than AIDS, tuberculosis and malaria combined. Joining more than 250 advocates from around the world, Adam Garone, co-founder and CEO of Movember, the world's largest charity for men's health, will present at the LIVESTRONG Global Cancer Summit in Dublin, Ireland, August 24 - 26.

27 Aug 2009

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

EDCTP welcomes project proposals as a response to the following calls: Tuberculosis vaccines, HIV/AIDS treatment and Member States Initiated projects.

27 Aug 2009

Lancet series examines health issues in South Africa

The journal Lancet published a series of articles examining health issues in South Africa, suggesting that "South Africa's health system is failing women and children in particular, but that new leadership could solve many of the problems," the Associated Press/msnbc.com reports (8/24).

27 Aug 2009

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

Guardian Technologies International, Inc. (OTCBB: GDTI) today announced that its Software Quality Assurance Team has completed all unit, component, integration, and systems tests of Signature Mapping TBDx™ (TBDx™) in preparation for September clinical trials in South Africa.

26 Aug 2009

Puricore announces closure of its new USD 2.1 million debt facility

PuriCore plc (LSE: PURI), the life sciences company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, today announces that it has closed on a new USD2.1 million debt facility with Republic First Bank.

26 Aug 2009

Smokers twice as likely to get active TB, study finds

"A study in Taiwan has found that smokers are twice as likely to develop active tuberculosis compared to people who have never smoked, prompting calls for policymakers to be tougher on smoking," Reuters reports (Lyn, 8/24).

26 Aug 2009

PuriCore reduces operating expenses by 14% in H1 2009 when compared with H1 2008

PuriCore (LSE: PURI), the life sciences company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, today announces its interim results for the six months ending June 30, 2009. An H1 2009 Operating and Financial Report and detailed financial results are available here at PuriCore’s website.

25 Aug 2009

TuBerculosis Vaccine Initiative receives $3 million grant from Gates Foundation

TuBerculosis Vaccine Initiative (TBVI) recently received a $3million grant for a three year term from the Bill & Melinda Gates Foundation. This grant enables the nonprofit organization to strengthen its fundraising and communication activities in order to increase awareness and support for tuberculosis (TB) vaccine research and raise funds for the development of safer and more effective vaccines.

25 Aug 2009

Health and Human Services Secretary to appoint Helene Gayle as the Chair of Presidential Advisory Council

Today, Secretary of Health and Human Services Kathleen Sebelius announced her intent to appoint Helene Gayle, MD, MPH to serve as the Chair of the Presidential Advisory Council on HIV/AIDS. Secretary Sebelius made the announcement in Atlanta at the 2009 National HIV Prevention Conference.

25 Aug 2009

Tuberculosis News and Research

Latest Tuberculosis News and Research

Also in global health news: Africa measles eradication; water, food security in South Asia; MDR-TB in Mumbai; SADC summit; U.S. Cuba embargo

Increase in Rifampicin dosage shortens tuberculosis treatment duration

Cimzia approved for treating adult patients with rheumatoid arthritis

Also in Global Health news: Flu, cholera in PNG; improving life awards; HIV/AIDS in Rwanda; men and maternal/child health; MDR-TB in India

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

Also in Global Health news: ARVs in Uganda; Brazil's fight against HIV/AIDS

Urine LAM-ELISA's sensitivity of 50.7% in identifying TB disappoints

Enzymes could be targeted to kill dangerous pathogens

Also in global health news: NTD study; false cholera cases in Zimbabwe; contaminated water in Kenya; doctor's strike ends

Clinical data added to ORENCIA labeling help treat patients with rheumatoid arthritis

European Medicines Agency validates Schering-Plough's MAA for nomegestrol acetate/17 beta-estradiol

Movember to present at the LIVESTRONG Global Cancer Summit

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

Lancet series examines health issues in South Africa

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

Puricore announces closure of its new USD 2.1 million debt facility

Smokers twice as likely to get active TB, study finds

PuriCore reduces operating expenses by 14% in H1 2009 when compared with H1 2008

TuBerculosis Vaccine Initiative receives $3 million grant from Gates Foundation

Health and Human Services Secretary to appoint Helene Gayle as the Chair of Presidential Advisory Council

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Tuberculosis News and Research

Latest Tuberculosis News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in